Brief: Hofseth Biocare Q3 EBITDA Loss Narrows To NOK 7.6 Mln
Nov 1 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* OPERATING REVENUES OF NOK 29.2M (16.9M) IN Q3 OF 2019
* OPERATIONAL PROFIT (EBITDA) FOR Q3 2019 WAS NEGATIVE NOK
7.6M
(14.7M)
Source text for Eikon: ID:nGNEbX6JVL
Further company coverage: HOFBC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering